ASSESSING THE COMPARATIVE EFFICACY OF INP104 FOR ACUTE TREATMENT OF MIGRAINE ATTACKS: A MATCHING-ADJUSTED INDIRECT COMPARISON

被引：0
|
作者：
Joshi, S. [1 ]
Aurora, S. K. [2 ]
Wang, S. [3 ]
Park, J. E. [4 ]
Wu, P. [4 ]
Keeping, S. T. [4 ]
Bariahtaris, S. [2 ]
Shrewsbury, S. [2 ]
机构：
[1] Dent Neurol Inst, Amherst, NY USA
[2] Impel NeuroPharma Inc, Seattle, WA USA
[3] Precis HEOR, W Vancouver, BC, Canada
[4] Precis HEOR, Vancouver, BC, Canada
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND7
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [21] Assessing the impact of a matching-adjusted indirect comparison in a Bayesian network meta-analysis
    Leahy, Joy
    Walsh, Cathal
    RESEARCH SYNTHESIS METHODS, 2019, 10 (04) : 546 - 568
  • [22] Comparative Clinical Efficacy of Sarilumab versus Upadacitinib over 12 Weeks: Matching-Adjusted Indirect Comparison Analysis
    Huizinga, Thomas
    Choy, Ernest
    Praestgaard, Amy
    van Hoogstraten, Hubert
    LaFontaine, Patrick R.
    Guyot, Patricia
    Aletaha, Daniel
    Mueller-Ladner, Ulf
    Tanaka, Yoshiya
    Curtis, Jeffrey R.
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [23] A matching-adjusted indirect comparison of trabectedin and pazopanib for the treatment of advanced, metastatic, leiomyosarcomas
    Jones, R. L.
    Blay, J-Y.
    Lecesne, A.
    Martin-Broto, J.
    Pontes, M. J.
    Fernandez Santos, J. M.
    Garcia San Andres, B.
    Wang, G.
    Wang, S.
    Shin, C. R.
    Maki, R.
    Patel, S.
    Demetri, G. D. S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [24] Acute treatment of migraine with INP104: Exploratory efficacy from the phase 3 open-label STOP 301 study
    Smith, T. R.
    Aurora, S. K.
    Hocevar-Trnka, J.
    Shrewsbury, S. B.
    HEADACHE, 2021, 61 : 108 - 108
  • [25] Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison
    Suzy Van Sanden
    Simona Baculea
    Joris Diels
    Sarah Cote
    Advances in Therapy, 2017, 34 : 1650 - 1661
  • [26] Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison
    Maksymowych, Walter P.
    Strand, Vibeke
    Nash, Peter
    Yazici, Yusuf
    Thom, Howard
    Hunger, Matthias
    Kalyvas, Chrysostomos
    Gandhi, Kunal K.
    Porter, Brian
    Jugl, Steffen M.
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (04) : 216 - +
  • [27] Comparative effectiveness of ozanimod versus dimethyl fumarate: results of a matching-adjusted indirect comparison
    Cohan, S.
    Kumar, J.
    Arndorfer, S.
    Zhu, X.
    Zivkovic, M.
    Tencer, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 140 - 140
  • [28] Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine
    Dafer, Rima M.
    Tietjen, Gretchen E.
    Rothrock, John F.
    Vann, Robert E.
    Shrewsbury, Stephen B.
    Aurora, Sheena K.
    HEADACHE, 2024, 64 (08): : 983 - 994
  • [29] Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials
    Signorovitch, James E.
    Wu, Eric Q.
    Betts, Keith A.
    Parikh, Kejal
    Kantor, Evan
    Guo, Amy
    Bollu, Vamsi K.
    Williams, Denise
    Wei, L. J.
    DeAngelo, Daniel J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1263 - 1271
  • [30] Comparative efficacy and safety of ozanimod versus teriflunomide for relapsing-remitting multiple sclerosis: a matching-adjusted indirect comparison
    Cohan, S.
    Kumar, J.
    Arndorfer, S.
    Zhu, X.
    Zivkovic, M.
    Tencer, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 140 - 140
12345